VVOS icon

Vivos Therapeutics
VVOS

Overview Fund Activity

29 hedge funds and large institutions have $10.9M invested in Vivos Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
29
Holders Change
+11
Holders Change %
+61.11%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
8
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.9M
2
PCM
2
Penn Capital Management
Pennsylvania
$1.11M
3
BA
3
Bard Associates
Illinois
$1.07M
4
ACM
4
Archon Capital Management
Washington
$1.06M
5
PCM
5
Perkins Capital Management
Minnesota
$804K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$65K
2
KJHP
2
K.J. Harrison & Partners
Ontario, Canada
$0
3
Creative Planning
3
Creative Planning
Kansas
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
APP
5
Alpha Paradigm Partners
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
WWM
26
Wagner Wealth Management
South Carolina
$1K 11 – –
TFA
27
Toth Financial Advisory
Virginia
$1K 8 +8 New
Walleye Capital
28
Walleye Capital
New York
$743 6,000 +6,000 New
KJHP
29
K.J. Harrison & Partners
Ontario, Canada
– – -1,817 Closed
Creative Planning
30
Creative Planning
Kansas
– – -1,240 Closed
Citadel Advisors
31
Citadel Advisors
Florida
– – -634 Closed
APP
32
Alpha Paradigm Partners
Illinois
– – -397 Closed
TRCT
33
Tower Research Capital (TRC)
New York
– – -15 Closed
CFGS
34
Concourse Financial Group Securities
Alabama
– – – –
Wells Fargo
35
Wells Fargo
California
$0 2 +1 +100%
1
2